France · Source-listed medicine information

France / CIS 68046787

MENVEO, poudre et solution pour solution injectable. Vaccin méningococcique des groupes A, C, W-135 et Y conjugué

poudre et solution pour solution injectable · intramusculaire

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formpoudre et solution pour solution injectable
Routeintramusculaire
Ingredient entries4
CountryFrance

Product identity

At a glance

Authorisation holder
GSK VACCINES SRL (ITALIE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 68046787

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for MENVEO, poudre et solution pour solution injectable. Vaccin méningococcique des groupes A, C, W-135 et Y conjugué
IngredientStrength / referenceSource role
OLIGOSIDE DE NEISSERIA MENINGITIDIS DU GROUPE A CONJUGUÉ À LA PROTÉINE CRM197poudre10 microgrammes d'oligoside de Neisseria meningitidis du groupe A0,5 ml de vaccin reconstituéSAGroup 1
OLIGOSIDE DE NEISSERIA MENINGITIDIS DU GROUPE Y CONJUGUÉ À LA PROTÉINE CRM197solution5 microgrammes d'oligoside de Neisseria meningitidis du groupe Y0,5 ml de vaccin reconstituéSAGroup 4
OLIGOSIDE DE NEISSERIA MENINGITIDIS DU GROUPE C CONJUGUÉ À LA PROTÉINE CRM197solution5 microgrammes d'oligoside de Neisseria meningitidis du groupe C0,5 ml de vaccin reconstituéSAGroup 2
OLIGOSIDE DE NEISSERIA MENINGITIDIS DU GROUPE W135 CONJUGUÉ À LA PROTÉINE CRM197solution5 microgrammes d'oligoside de Neisseria meningitidis du groupe W1350,5 ml de vaccin reconstituSAGroup 3

Pack references

Presentations (1)

1 flacon(s) en verre - 1 flacon(s) en verre

CIP13 3400921702903

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68046787 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →